>>> US Gapping up

Gapping up
In reaction to earnings/guidance:
  • WGS +12.6%, DFIN +5.9%, TH +4.8%, ETR +2.3%, NE +2%, TNC +2%, OTTR +2%, BHP +1.7%, SOHU +1.6%, CC +1.5%, AXSM +1.4%, GPC +1.3%, VMI +1.1%
Other news:
  • SLDB +84.1% (Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003)
  • IPHA +30.9% (receives Breakthrough Therapy Designation to Lacutamab from FDA)
  • PCT +12.4% (Duquesne (Stanley Druckenmiller) discloses new portfolio position)
  • STZ +8.6% (Berkshire Hathaway new position)
  • SPIR +4.1% (discloses Delaware Court of Chancery update)
  • PONY +4% (Soros Fund new position)
  • VG +3.7% (commences commercial operations at Calcasieu Pass)
  • SEG +2.5% (Pershing Square increased stake)
  • ZK +2.5% (closes strategic integrated transactions)
  • MATW +2.3% (U.S. District Court Judge once again denies Tesla's (TSLA) request to block Matthews International from selling its innovative dry battery electrode solutions to others; Barington Capital Calls on Matthews International Shareholders to Elect Ana Amicarella, Chan Galbato and James Mitarotonda to the Matthews Board to Help Restore Good Governance and Drive Value Creation)
  • LUV +2.1% (reduces corporate workforce)
  • CMRX +2.1% (FDA accepts its NDA seeking accelerated approval for dordaviprone)
  • EXTR +2% ($200 million share repurchase authorization)
  • MU +1.8% (Duquesne (Stanley Druckenmiller) discloses new portfolio position)
  • OXY +1.6% (Berkshire Hathaway increased stake)
  • KWEB +1.5% (Soros Fund new position)
  • CWEN +1.4% (div raise)
  • SIRI +1.3% (Berkshire Hathaway increased stake)
  • DPZ +1.3% (Berkshire Hathaway increased stake)
  • SKX +1% (Duquesne (Stanley Druckenmiller) discloses new portfolio position)
  • GME +1% (announces that as part of its evaluation of its international assets, the Company intends to pursue a sale of its operations in France and Canada)
  • SDRL +0.9% (Third Point new position)
  • GSK +0.8% (receives FDA approval for 5-in-1 meningitis vaccine)
  • VMC +0.7% (increases quarterly cash dividend to $0.49/share from $0.46/share)